Open AccessAbstract 5705: Mechanisms and therapeutic implications of hypermutation in gliomas
Author(s) -
Mehdi Touat,
Yvonne Y. Li,
Adam N. Boynton,
Liam F. Spurr,
Bryan Iorgulescu,
Craig L. Bohrson,
Isidro Cortés-Ciriano,
Jack Geduldig,
Kristine Pelton,
Mary Jane Lim-Fat,
Sangita Pal,
Shakti Ramkissoon,
Frank Dubois,
Charlotte Bellamy,
Naomi Currimjee,
Kenin Qian,
Seth Malinowski,
Aniket Shetty,
Kin-Hoe Chow,
Maïté Verreault,
Erell Guillerm,
Samy Ammari,
Frédéric Beuvon,
Karima Mokhtari,
Agustí Alentorn,
Caroline Dehais,
Caroline Houillier,
Florence LaigleDonadey,
Dimitri Psimaras,
Alexandre Carpentier,
Philippe Cornu,
Césari Laurent,
Bertrand Mathon,
Jill S. BarnholtzSloan,
Arnab Chakravarti,
Wenya Linda Bi,
Garrett M. Frampton,
Marc Sanson,
Brian M. Alexander,
Andrew D. Cherniack,
Patrick Y. Wen,
David A. Reardon,
Aurélien Marabelle,
Peter J. Park,
Ahmed Idbaïh,
Rameen Beroukhim,
Pratiti Bandopadhayay,
Franck Bielle,
Keith L. Ligon
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-5705
Subject(s) - somatic hypermutation , temozolomide , microsatellite instability , dna mismatch repair , cancer research , biology , glioma , apobec , mutation , dna repair , genetics , gene , genome , microsatellite , b cell , antibody , allele